Acorah Software Products - Accounts Production 19.2.450 false true 31 December 2024 8 January 2024 false 1 January 2025 31 December 2025 31 December 2025 15394586 Dr Harry Williams Dr Sakthivel Vaiyapuri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15394586 2024-12-31 15394586 2025-12-31 15394586 2025-01-01 2025-12-31 15394586 frs-core:CurrentFinancialInstruments 2025-12-31 15394586 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 15394586 frs-core:OtherResidualIntangibleAssets 2025-12-31 15394586 frs-core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 15394586 frs-core:OtherResidualIntangibleAssets 2024-12-31 15394586 frs-core:SharePremium 2025-12-31 15394586 frs-core:ShareCapital 2025-12-31 15394586 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 15394586 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15394586 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 15394586 frs-bus:SmallEntities 2025-01-01 2025-12-31 15394586 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15394586 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 15394586 frs-bus:Director1 2025-01-01 2025-12-31 15394586 frs-bus:Director2 2025-01-01 2025-12-31 15394586 frs-countries:EnglandWales 2025-01-01 2025-12-31 15394586 2024-01-07 15394586 2024-12-31 15394586 2024-01-08 2024-12-31 15394586 frs-core:CurrentFinancialInstruments 2024-12-31 15394586 frs-core:SharePremium 2024-12-31 15394586 frs-core:ShareCapital 2024-12-31 15394586 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31
Registered number: 15394586
Antigenika Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2025
striveX Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 15394586
2025 2024
as restated
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 5 336 230
336 230
CURRENT ASSETS
Debtors 6 16,768 8
Cash at bank and in hand 49,747 2,496
66,515 2,504
Creditors: Amounts Falling Due Within One Year 7 (718,594 ) (80,735 )
NET CURRENT ASSETS (LIABILITIES) (652,079 ) (78,231 )
TOTAL ASSETS LESS CURRENT LIABILITIES (651,743 ) (78,001 )
NET LIABILITIES (651,743 ) (78,001 )
CAPITAL AND RESERVES
Called up share capital 8 314 100
Share premium account 331,002 -
Profit and Loss Account (983,059 ) (78,101 )
SHAREHOLDERS' FUNDS (651,743) (78,001)
Page 1
Page 2
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Harry Williams
Director
31/05/2026
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Antigenika Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15394586 . The registered office is Co StriveX, Beacon House, Ibstone Road, Stokenchurch, High Wycombe, HP14 3FE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are Website costs and Development costs. The website is amortised to the profit and loss account over its estimated economic life of 5 years.
Research and development
Research expenditure is written off in the year in which it is incurred.
Development expenditure incurred is capitalilsed as an intangible asset only when all of the following critera are met:
  • It is technically feasible to complete the intangible asset so that it will be available for use or sale;
  • There is the intention to complete the intangible asset and use or sell it;
  • There is the ability to use or sell the intangible asset;
  • The use or sale of the intangible asset will generate probable future economic benefits;
  • There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and
  • The expenditure attributable to the intangible asset during its development can be measured reliably.
Expenditure that does not meet the above criteria is expensed as incurred.
2.3. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 1)
2 1
Page 3
Page 4
4. Prior Period Adjustment
Changed classification of R&D costs from Intanglibe assets to expenses on Profit & Loss.
5. Intangible Assets
Other
£
Cost
As at 1 January 2025 287
Additions 204
As at 31 December 2025 491
Amortisation
As at 1 January 2025 57
Provided during the period 98
As at 31 December 2025 155
Net Book Value
As at 31 December 2025 336
As at 1 January 2025 230
6. Debtors
2025 2024
as restated
£ £
Due within one year
Trade debtors 7,522 -
Other debtors 9,246 8
16,768 8
7. Creditors: Amounts Falling Due Within One Year
2025 2024
as restated
£ £
Trade creditors 1 -
Other creditors 903,912 80,735
Taxation and social security (185,319 ) -
718,594 80,735
8. Share Capital
2025 2024
as restated
£ £
Allotted, Called up and fully paid 314 100
Share Capital at the beginning of the year:       £100
Shares issued during the period:                     £214
Share Capital at the end of the year:               £314
Page 4